Broad genomic sequencing improves survival in advanced lung cancer patients

New research published in the November 2026 issue of JNCCN shows that patients with advanced non-small cell lung cancer (NSCLC) have longer survival when treated after broad genomic sequencing (BGS) testing. This approach tests a large panel of genes before treatment, outperforming limited biomarker testing of only one or two genes.

Originally published by gnews